Michael Gelband’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34,077
Closed -$2.55M 2101
2026
Q1
$2.55M Buy
+34,077
New +$2.79M 0.02% 675
2025
Q1
Sell
-26,413
Closed -$2.34M 2025
2024
Q4
$2.34M Buy
26,413
+20,609
+355% +$1.84M 0.02% 667
2024
Q3
$491K Sell
5,804
-4,563
-44% -$405K ﹤0.01% 1192
2024
Q2
$958K Buy
+10,367
New +$1.05M 0.01% 1033
2022
Q1
Sell
-2,619
Closed -$250K 2701
2021
Q4
$250K Buy
+2,619
New +$263K ﹤0.01% 1726
2021
Q3
Sell
-1,761
Closed -$204K 2661
2021
Q2
$204K Sell
1,761
-1,887
-52% -$217K ﹤0.01% 1970
2021
Q1
$380K Buy
+3,648
New +$454K 0.01% 1524

Other funds holding USPH

Michael Gelband's USPH Position: Q2 2026 in Review

Michael Gelband sold out of US Physical Therapy (USPH) in Q2 2026, closing a stake of 34,077 shares — an estimated $2.55M sold.

Michael Gelband first reported a position in USPH in Q1 2021 and held it in 7 quarters. The position peaked at $2.55M in Q1 2026. 216 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Michael Gelband reported no remaining US Physical Therapy position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 34,077 US Physical Therapy shares in Q2 2026, an estimated $2.55M.
  • Michael Gelband first reported a position in US Physical Therapy in Q1 2021 and held it in 7 quarters.
  • Michael Gelband's US Physical Therapy position peaked at $2.55M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.